Skye Bioscience, Inc. Common Stock (SKYE)

NASDAQ HEALTHCARE
$0.57 -2.03% Daily RSI (14) 32 Neutral As of Jul 31, 2026 Add Alert

Moving Averages

SMA 200
$0.92
Price below

Company Profile

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$20.39M
P/E Ratio
None
EPS
$-1.37
Beta
2.944
Dividend Yield
0.00%
52-Week High
$4.99
52-Week Low
$0.561

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 46.0
VRTX
Vertex Pharmaceuticals Inc
RSI 48.0
CRSP
CRISPR Therapeutics AG
RSI 42.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 42.0
MRNA
Moderna Inc
RSI 41.0
VKTX
Viking Therapeutics Inc
RSI 36.0
SRPT
Sarepta Therapeutics Inc
RSI 32.0
EDIT
Editas Medicine Inc
RSI 39.0
IOVA
Iovance Biotherapeutics Inc
RSI 42.0
NVAX
Novavax Inc
RSI 30.0

Data last updated: July 31, 2026 at 11:59 PM EDT

Track SKYE for free

Get e-mail RSI alerts when Skye Bioscience, Inc. Common Stock enters oversold or overbought territory. Free forever.

Add Alert